This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Hinova Pharmaceuticals Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Innovations and Contributions of Inventor Haibo Li
Introduction
Haibo Li is a distinguished inventor based in Sichuan, China, recognized for his significant contributions to the field of pharmaceuticals. Holding three patents, Haibo's work focuses on novel compounds with the potential to address various medical conditions, particularly those related to metabolic diseases.
Latest Patents
Haibo Li's latest patents demonstrate his innovative approach to chemistry and pharmacology. One of his notable inventions is a halogen-substituted phenylate compound, which has been proven to exhibit enhanced agonist activity towards THR-beta. Compared to the control compound MGL-3196, this new compound showcases a remarkable increase in selectivity on THR-beta/THR-alpha, making it a promising candidate for the development of therapies to treat adaptation diseases such as dyslipidemia, hypercholesteremia, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease. Additionally, he has developed a novel method for synthesizing deuterated amides and deuterated sulfonamides, highlighting his expertise in synthetic chemistry.
Career Highlights
Currently, Haibo Li is associated with Hinova Pharmaceuticals Inc., where his research is directed towards creating effective pharmaceutical solutions. Over the years, he has garnered recognition in the scientific community for his innovative methodologies and groundbreaking research in drug development.
Collaborations
Haibo works alongside talented colleagues, including Wu Du and Yuanwei Chen, fostering a collaborative environment that enhances their collective research efforts. These partnerships are essential in driving forward their innovative projects, facilitating the exchange of ideas and expertise.
Conclusion
Haibo Li's contributions to the field of pharmaceuticals through his patents underline the importance of innovation in overcoming complex health challenges. His ongoing research and collaborative work continue to push the boundaries of what is possible in drug development, making significant strides toward effective treatments for various ailments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile